Symbiotics has recently opened its second office in Switzerland at Forchstrasse 280 in the city center of Zurich. The office is run by a new Head of Investor Relations, Christoffer Dahlberg. His predecessor, Fabio Sofia, was made Director of the new Business Development unit, which includes the investor relations, market research and new product development activities.
Christoffer Dahlberg brings 17 years of experience to the company in the area of alternative investment funds and structured products and has worked with both institutional and wholesale clients in several European markets. In 2005, he spearheaded the launch of the Dual Return Fund – Vision Microfinance, one of the first and now one of the largest microfinance funds in Europe. His role will be to grow the business in German-speaking Switzerland as well as in the Benelux. He will also manage a team of investor relations managers located in both Geneva and London.
Zurich office address:
Tel +41 (0) 43 499 8789
Symbiotics is an investment company specialized in emerging, sustainable and inclusive finance which offers market research, investment advisory and asset management services. It is a regulated asset manager of collective investment schemes by FINMA, the Swiss Financial Market Supervisory Authority and has an advisory license from the FCA, the Financial Conduct Authority in the UK. The company is headquartered in Geneva, with offices in London, Zurich, Mexico City, Singapore and Cape Town with a staff of over seventy professionals. Since its inception, Symbiotics has invested over USD 2.2 billion in more than 200 microfinance institutions in 50 emerging countries, working with more than 28 investment funds and many institutional investors.
For more information:
00 41 (0)22 338 1570 (direct)
00 41 (0)22 338 1540